1. ALLA AKTIER
  2. NYHETER
  3. CHORDATE MEDICAL

Chordate Medical

Nyheter Chordate Medical Nyheter alla bolag

Chordate Medical trains neurologists in Liverpool – initiating the introduction of Ozilia™ Migraine

During a neurology symposium with around 60 participants at The Walton Centre NHS Foundation Trust in Liverpool on October 6-7, Chordate Medical conducted a separate training on the company's treatment method, Ozilia™ Migraine (formerly K.O.S). The Walton Centre is a leading neurology hospital in the UK, serving an area of about four million people, and the medical team's intention is to begin implementing Ozilia™ into their treatment arsenal, starting with their private clinic side.

“Together with our clinical application specialist, Petra Libert, I had the opportunity to train seven specialist doctors and nurses on the practical use of the Ozilia™ migraine treatment. It is very rewarding to work directly with the specialists who actually performs the treatment and helps patients, while also taking the first practical steps towards increasing business," says Anders Weilandt, Chordate Medical CEO.

The Walton Centre is a specialist hospital providing comprehensive neurological, neurosurgical, pain management, and rehabilitation services. The hospital has about 1,450 employees and treats over 140,000 patients each year.

For more information, please contact:
Anders Weilandt, CEO
anders.weilandt@chordate.com
Cell: +46 733-874277

About Chordate
Chordate Medical Holding AB (publ) is a medical technology company that has developed, patented and CE-marked a neuromodulation and drug-free treatment technology for chronic migraine and chronic nasal congestion (rhinitis), Kinetic Oscillation Stimulation (K.O.S). The treatment has clinically proven efficacy according to a recent study, and is marketed in Finland, Germany, the UK, Italy, Israel, and Saudi Arabia. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm (ticker: CMH). Read more at www.chordate.com

The company's Certified Adviser on Nasdaq First North Growth Market Stockholm is Västra Hamnen Corporate Finance AB.

N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail.

Attachments
Chordate Medical trains neurologists in Liverpool – initiating the introduction of Ozilia™ Migraine

Datum 2023-10-10, kl 08:40
Källa MFN
Bifogade filer
Chordate Medical trains neurologists in Liverpool – initiating the introduction of Ozilia™ Migraine
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!